Clinical trial

Exploratory Study of Precise Therapy for Advanced Tumor Patients With Malignant Hydrothorax or Ascites by Using PTC Drug Sensitivity Testing

NCT06413212

Study summary

ClinicalTrials.gov

Exploratory Study of Precise Therapy for Advanced Tumor Patients With Malignant Hydrothorax or Ascites by Using PTC Drug Sensitivity Testing

Design: OBSERVATIONAL · Status: RECRUITING · Phase: Not specified

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DIAGNOSTIC_TEST · Unmapped registry intervention Patient-derived tumor-like cell clusters (PTC) drug sensitivity testing. Find medicine records · Find other trials using this name

StatusRECRUITING

Study typeOBSERVATIONAL

Start date2023-08-04

PhaseN/A

Conditions

Lung Cancerverified · MONDO: lung cancer

Breast Cancerverified · MONDO: breast cancer

Gastric Cancerverified · MONDO: gastric cancer

Colorectal Cancerverified · MONDO: colorectal cancer

Interventions

Patient-derived tumor-like cell clusters (PTC) drug sensitivity testing.DIAGNOSTIC_TEST

Sponsors & collaborators

Liu Huanglead sponsor

Beijing GeneX MedLab Co., Ltdcollaborator

Mapped research locations

WuhanHubei, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06413212 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.